Skip to content

11/3

Online / USA 11.3.-20.4.2025

AMPlify – Accelerated US Market Entry for Finnish Healthcare Companies

In collaboration with Mayo Clinic


Application Period: March 11 – April 20, 2025 (All applications must be submitted by April 20, 2025)

Further information

 

Titta Houni 
Senior Advisor 
New York, USA 
titta.houni (at) businessfinland.fi 


Renne Kaseva 
Senior Advisor 
Helsinki 
renne.kaseva (at) businessfinland.fi  

AMPlify is an established platform designed to advance Finnish healthcare companies' US market readiness and entry. Expanding upon the successful Nordic AMPlify and Gazelle programs, AMPlify is a complete ecosystem that brings Finnish companies and Mayo Clinic together.

The US market represents 40% of the global healthcare market, and more than 30% of new technologies are joint ventures with non-US entities. American health systems are transforming their innovation centers into international co-development ventures. AMPlify is leading this transition and Mayo Clinic has selected Finland as a strategy focus area.

Mayo Clinic, one of the leading health systems globally, constantly seeks to provide its patients the best and most efficient care. They recognize that this can only be accomplished through constant innovation across the entire continuum of care. Hence, there is a need to find the best ways to improve care, reduce costs, and improve the quality of life for all patients.

Co-development is key to essential, and working with new companies and ideas is a proven pathway. The need for more and better digital tools is real and visible. Now is the time to focus resources on US entry through AMPlify with local champions. AMPlify is a strategic and competitive advantage.

AMP is a carefully thought out and curated program consisting of workshops, one-on-one mentoring, and webinars with leading US healthcare players including providers, VCs, strategics, and Mayo Clinic experts. Participating companies will receive feedback, help with the value proposition and focus, and access to KOLs while gaining market and business insight. All aspects of commercial and clinical success will be covered. 

AMPlify 2025 will accommodate 10–12 selected companies, offering a structured pathway to accelerate U.S. market entry.

  • Virtual program introduction: March 11, 2025
  • Application Period: March 11 – April 20, 2025 (All applications must be submitted by April 20, 2025)
  • Cohort Selection: Announced in June 2025
  • Mentoring Sessions: Begin following cohort selection
  • In-Person Kickoff: Helsinki, August 2025
  • One-on-One mentoring: Each company will receive two individual mentoring sessions (60–90 minutes each)
  • Workshops & Webinars: Virtual bi-weekly sessions from September to October 2025
  • U.S. Market Visit: On-site visit to Mayo Clinic, Rochester, Minnesota, in November 2025
  • Participation Fee: $6,000 (travel expenses to Rochester not included)
  • Eligible companies can apply for Business Finland funding, or the costs may be included in the ongoing DTA/NIY project. Discuss this with your BF contact.